64-Page FBI Curaleaf File Exposes DEA Registration Compliance Risk

For cannabis operators and their counsel, the FBI's partial release of records on Curaleaf is a compliance wake-up call disguised as an old investigation. The documents show federal prosecutors used two grand juries to examine beneficial ownership, foreign financing, and potential money-laundering. Even with no charges, the 64 released pages and 147 withheld under grand jury secrecy signal that state licensing is no proxy for federal registration readiness.

On August 13, 2026, MMJ International Holdings issued a statement arguing that newly released FBI records concerning Curaleaf illustrate the federal scrutiny that state-licensed marijuana operators will face as they seek registration from the Drug Enforcement Administration. The records, obtained by researcher Joe Lloyd through a Freedom of Information Act request and reported by The Newsground on August 11, include 64 pages released by the FBI and 147 pages withheld, most of them protected under grand jury secrecy rules. The statement was distributed through ACCESS Newswire and is clearly an advocacy communication, so its broader industry warnings should be read as argument rather than independent confirmation. Still, the underlying documents point to a meaningful regulatory shift that legal and compliance teams should not dismiss.

“

For cannabis operators and their counsel, the FBI's partial release of records on Curaleaf is a compliance wake-up call disguised as an old investigation.

According to the reporting, federal authorities examined financial activity associated with Curaleaf in connection with potential money-laundering and public-corruption violations. Two federal grand juries examined the matter, one in Manhattan and another in Philadelphia, and both proceedings ended without criminal charges. Curaleaf told The Newsground that it was never notified that it was a subject with respect to any FBI investigation, that it complies with ownership-disclosure requirements in every jurisdiction where it holds cannabis licenses, and that Roman Abramovich does not, to the company's knowledge, directly or indirectly own Curaleaf shares. No criminal wrongdoing by Curaleaf was established through the investigations described in the released records. The absence of charges is important, but the existence of two grand jury proceedings and 147 withheld pages means the full scope of the inquiry is not publicly known.

The most consequential element for the cannabis industry is not that an investigation occurred or that it ended without charges. It is the scope of the questions federal investigators reportedly examined: beneficial ownership, foreign financing, compliance histories, and diversion controls. MMJ International Holdings contends that entry into the federal controlled-substances system may expose applicants to scrutiny far beyond state licensing reviews. That assertion has real doctrinal weight. Under the Controlled Substances Act, entities that manufacture, distribute, or dispense controlled substances must register with the DEA. Marijuana remains Schedule I federally, but any rescheduling pathway, research registration, or pharmaceutical development involving cannabis would place state-licensed operators into a federal registration environment with substantially more demanding due diligence.

For legal and regulatory counsel, the Curaleaf file offers a preview of the investigative tools federal agencies can deploy. Grand juries in two districts indicate that federal prosecutors were willing to use criminal process, not merely administrative subpoenas, to examine corporate ownership and financial structures. Grand jury secrecy explains why 147 pages were withheld, but the fact that records were still produced under FOIA highlights the reputational risk that can arise even when no charges are filed. Operators should anticipate that beneficial ownership registers, capital source documentation, related-party transactions, and diversion-control policies will all be subject to federal review before DEA registration is granted.